Health Care/Hospital

AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine

SEATTLE, April 24, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with AdaptVac to develop and produce a COVID-19 vaccine. AdaptVac, together with its EU Horizon 2020 sponsored PREVENT-nCoV con...

2020-04-24 14:50 3526

TAUZIA Hotels Supports Healthcare Professionals with Meal Donation Initiatives for Hospitals across Indonesia

JAKARTA, Indonesia, April 24, 2020 /PRNewswire/ -- Given the current COVID-19 global issue, TAUZIA Hotels is committed to assist the community in need during this pandemic, particularly the healthcare professionals who are working on the frontline to contain the disease. The company is working to...

2020-04-24 11:26 3591

Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC

SUZHOU, China, April 24, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jo...

2020-04-24 07:50 7147

Empire State Building Launches #HeroesShineBright Campaign To Show Thanks To First Responders

A week of lightings for First Responder organizations and Essential Workers kicks offApril 24 NEW YORK, April 24, 2020 /PRNewswire/ -- The Empire State Building (ESB) today announced the launch of #HeroesShineBright, a weeklong campaign to give thanks to every person putting their lives on the l...

2020-04-24 04:28 6165

AliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring

Alliance and Equity Investment Improves Access to Remote Patient Care for 70 Percent of the Global Population MOUNTAIN VIEW, California and KYOTO, Japan, April 24, 2020 /PRNewswire/ --  AliveCor, a leader in personal ECG products, and OMRON Healthcare, Co., Ltd., a global leader in personal heart...

2020-04-24 01:01 2171

First Patient in Treatment in RhoVac's Clinical Phase IIb Study in Germany

STOCKHOLM, April 24, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 23rd April 2020, that the first patient in Germany is in treatment in the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac"). The first patient in Germany is in treatment...

2020-04-24 00:37 1952

Henlius receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)

SHANGHAI, April 23, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspectio...

2020-04-23 22:02 3648

Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies

AUSTIN, Texas, April 23, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it is actively developing a COVID-19 triage test aiming to predict the likelihood that an individual who is COVID-19 positive will develop complications and severe disease, usi...

2020-04-23 20:30 6738

Lianhua Qingwen Listed in the Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos

SHIJIAZHUANG, China, April 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that Lianhua Qingwen capsules (granules) have been added to the "Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme forLaos" (Trial Version II) as the fourth traditional Chinese medicine to tre...

2020-04-23 20:00 6236

Minister for Foreign Affairs Dr Vivian Balakrishnan's Participation in the ASEAN-US Special Foreign Ministers' Meeting on COVID-19

SINGAPORE, April 23, 2020 /PRNewswire/ -- Minister for Foreign Affairs Dr Vivian Balakrishnan at the Videoconference for the ASEAN-US Special Foreign Ministers' Meeting on COVID-19. Minister for Foreign Affairs Dr Vivian Balakrishnan at the V...

2020-04-23 19:06 2382

Taiwan Textile Industry Actively Helping the United States and Global Partners to Combat COVID-19 Pandemic

TAIPEI, April 23, 2020 /PRNewswire/ -- Taiwan Textile Federation (TTF), by integrating upstream, midstream, and downstream textile industries and with the help of textile manufacturers such as Formosa Plastic Group, Formosa Chemicals & Fibre Corporation, Far Eastern New Century Corporation, KNH E...

2020-04-23 19:00 2558

Signifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal(R) Device Clinical Trials

LONDON, April 23, 2020 /PRNewswire/ -- Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that it is partnering with twenty-seven Key Opinion Leaders in Sleep to test and build awareness around its Snoozeal® product in the lead up to its commerc...

2020-04-23 19:00 1852

MiRXES to mass produce and distribute A*STAR Singapore's tested and proven SARS-CoV-2 RT-PCR test

SINGAPORE, April 23, 2020 /PRNewswire/ -- MiRXES, a homegrown Singapore-based biotech, has received Provisional Authorisation from the Health Sciences Authority (HSA)Singapore, to supply the Fortitude Kit SARS-CoV-2 real-time RT-PCR[1] test. With technology licensed from Singapore's Agency for Sc...

2020-04-23 18:04 3191

Fighting the COVID-19 Crisis with Technology; PALO IT Develops "Virtual Bed" App For Remote Patient Care

SINGAPORE, April 23, 2020 /PRNewswire/ -- PALO IT, an international 'Tech for Good' consultancy specialising in human-centered design, Agile software development, and tech transformation, is delighted to announce that it has developed an app to help healthcare professionals provide care for large...

2020-04-23 15:29 3797

Vinamilk Gives Out Milk and Face Masks to Under-Privileged Children During COVID-19 Pandemic

HO CHI MINH CITY, Vietnam, April 23, 2020 /PRNewswire/ -- 2020 has been a challenging year for the global economy due to the major impact of the Coronavirus pandemic. This, in turn, affects people of all ages.Under-privileged children, especially, are amongst the most severely impacted and expose...

2020-04-23 13:42 3570

Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection

MIAMI, April 23, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and...

2020-04-23 13:00 2427

New Early Breast Cancer Drug Available Now In Singapore

* NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence by 42% in women with early-stage, HER2+/HR+ breast cancer and who co...

2020-04-23 12:33 2158

Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs

BANGALORE, India; WILMINGTON, Delaware and ADELAIDE, Australia, April 23, 2020 /PRNewswire/ --  Bugworks Research Inc , a global biopharma start-up designing novel broad-spectrum antibiotics, announced the completion ...

2020-04-23 11:30 3170

Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)

SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics Inc. announced the successful FDA IND approval of IMC-002 under a development and manufacturing agreement with Samsung Biologics since 2018. As a result, ImmuneOncia will begin Phase 1 ...

2020-04-23 08:00 1471

OncoQuest Announces Signing of a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund the Oregovomab Phase 3 Clinical Trial in Frontline Ovarian Cancer

EDMONTON, Alberta, April 23, 2020 /PRNewswire/ -- OncoQuest Inc., ("OncoQuest" or the "Company") a privately held, cancer immunotherapy company today announced that it has entered into a definitive agreement to sell its clinical and preclinical immunotherapy development assets to Dual Industrial ...

2020-04-23 01:38 8239
1 ... 788789790791792793794 ... 847

Week's Top Stories